Evidence map›Paper›PMID 42838949›Full record

ArticleNature communications2026

System-wide investments generate health and enhance HIV, TB and malaria control in Malawi.

Tara D Mangal, Sakshi Mohan, Margherita Molaro, Joseph Collins, Tim Colbourn, Eva Janoušková, Rachel E Murray-Watson, Dominic Nkhoma, Andrew Phillips, Bingling She and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tara D MangalMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK. t.mangal@imperial.ac.uk.ORCID 0000-0001-9222-8632
Sakshi MohanCentre for Health Economics, University of York, York, UK. sakshi.mohan@york.ac.uk.ORCID 0000-0002-1268-1769
Margherita MolaroMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.ORCID 0000-0002-1841-4274
Joseph Collins *Institute for Global Health, University College London, London, UK.ORCID 0000-0003-4801-7218
Tim Colbourn *Institute for Global Health, University College London, London, UK.ORCID 0000-0002-6917-6552
Eva Janoušková *Institute for Global Health, University College London, London, UK.ORCID 0000-0002-4104-0119
Rachel E Murray-Watson *MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Dominic Nkhoma *Health Economics and Policy Unit, Kamuzu University of Health Sciences, Blantyre, Malawi.
Andrew Phillips *Institute for Global Health, University College London, London, UK.ORCID 0000-0003-2384-4807
Bingling She *MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Pakwanja D Twea *Department of Planning and Policy Development, Ministry of Health and Population, Lilongwe, Malawi.
Simon Walker *Centre for Health Economics, University of York, York, UK.ORCID 0000-0002-5750-3691
Paul RevillCentre for Health Economics, University of York, York, UK.
Timothy B HallettMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.ORCID 0000-0002-9681-0424

Funding

RCUK | Medical Research Council (MRC) MR/X020258/1Wellcome TrustWellcome Trust (Wellcome) 223120/Z/21/Z
6 · The paper itself

Abstract

Global health initiatives have expanded access to HIV, tuberculosis, and malaria services in low-income countries, yet these programmes often operate within fragile health systems where shortages of healthcare workers and essential medicines limit their effectiveness and sustainability. Evaluating investments in health system capacity remains challenging because their benefits are difficult to attribute. Here, using a dynamic microsimulation model of Malawi's health system, we show that health system strengthening investments alone could avert 11.4% of disability-adjusted life years between 2025 and 2035, delivering a return of $26.1 per dollar invested. Combining system strengthening with HIV, tuberculosis, and malaria programme expansion produces three times greater health impact than disease-focused investment alone, delivering a return of $11.7 per dollar invested compared with $5.4 for disease-focused expansion alone. These findings support a shift toward integrated global health financing strategies that combine health system strengthening with disease-targeted programmes.

Indexed as

Delivery of Health CareHIV InfectionsInvestmentsMalariaTuberculosisDisability-Adjusted Life YearsHumansMalawi

Identifiers

PMID42838949
PMCPMC13642251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.